AFT reports half-year loss despite top total sales

Dual-listed AFT Pharmaceuticals has reported a $2.45 million interim net loss, down 235% on the prior period’s $1.8m profit, as major customers lowered their inventories and Asian sales were hurt by a prolonged doctors’ strike.

It made an operating loss of $1.8m for the first half, compared to.